Why the study?
PLA2G16 was recently identified as a pan-enterovirus host factor and drug target, prompting investigation into possible mechanisms of viral evasion.
The study identifies how enterovirus D68 can bypass the host factor PLA2G16 through engagement with sulfated glycosaminoglycans, which induces virion destabilization and genome release.
Answers are grounded in this paper and cite their sources.
Does not change EV-D68 management; leaves open sGAGs as antiviral targets pending human validation.
Enteroviruses are a major cause of human disease. Adipose-specific phospholipase A2 (PLA2G16) was recently identified as a pan-enterovirus host factor and potential drug target. In this study, we identify a possible mechanism of PLA2G16 evasion by employing a dual glycan receptor-binding enterovirus D68 (EV-D68) strain. We previously showed that this strain does not strictly require the canonical EV-D68 receptor sialic acid. Here, we employ a haploid screen to identify sulfated glycosaminoglycans (sGAGs) as its second glycan receptor. Remarkably, engagement of sGAGs enables this virus to bypass PLA2G16. Using cryo-EM analysis, we reveal that, in contrast to sialic acid, sGAGs stimulate genome release from virions via structural changes that enlarge the putative openings for genome egress. Together, we describe an enterovirus that can bypass PLA2G16 and identify additional virion destabilization as a potential mechanism to circumvent PLA2G16.
No takes yet. Share an insight, caveat, or question.
Baggen et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: